Short Interest in Carmell Co. (NASDAQ:CTCX) Increases By 968.9%

Carmell Co. (NASDAQ:CTCXGet Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 391,200 shares, an increase of 968.9% from the September 30th total of 36,600 shares. Approximately 2.9% of the company’s stock are short sold. Based on an average daily volume of 4,500,000 shares, the short-interest ratio is currently 0.1 days.

Carmell Price Performance

CTCX remained flat at $0.35 on Friday. The company’s stock had a trading volume of 549,899 shares, compared to its average volume of 1,467,444. The company has a 50-day simple moving average of $0.48 and a two-hundred day simple moving average of $1.35. Carmell has a 52 week low of $0.29 and a 52 week high of $4.31.

Carmell (NASDAQ:CTCXGet Free Report) last announced its earnings results on Wednesday, August 14th. The company reported ($0.16) earnings per share for the quarter. The company had revenue of $0.01 million during the quarter.

Institutional Investors Weigh In On Carmell

A hedge fund recently bought a new stake in Carmell stock. Hubbell Strickland Wealth Management LLC bought a new stake in Carmell Co. (NASDAQ:CTCXFree Report) in the 1st quarter, according to its most recent filing with the SEC. The fund bought 12,548 shares of the company’s stock, valued at approximately $32,000. Hubbell Strickland Wealth Management LLC owned 0.07% of Carmell at the end of the most recent reporting period. Institutional investors own 24.22% of the company’s stock.

About Carmell

(Get Free Report)

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

Featured Articles

Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.